EDGAR Filing Documents for 0001104659-17-032367

Form CORRESP - Correspondence:

SEC Accession No. 0001104659-17-032367

Filing Date

2017-05-12

Accepted

2017-05-12 17:31:11

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	34791
	Complete submission text file	0001104659-17-032367.txt		35764

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406

Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 6108166640

Nabriva Therapeutics Plc (Filer) CIK: 0001703287 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations